Biomeme's platform utilizes real-time PCR technology and a mobile app to enable on-site DNA diagnostics and disease surveillance without the need for traditional lab equipment. This system provides rapid pathogen identification and monitoring for healthcare, agriculture, and environmental applications, enhancing response capabilities in various fields.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional DNA diagnostics and disease surveillance often require specialized lab equipment, limiting accessibility and speed, especially in remote locations or during rapid response situations. The need for off-site analysis can delay critical decision-making in healthcare, agriculture, biodefense, and environmental monitoring.
Solution
Biomeme offers a portable real-time PCR platform that enables on-site DNA diagnostics and disease surveillance, eliminating the reliance on conventional laboratory infrastructure. The system combines a mobile device, sample preparation, and analysis tools to facilitate rapid pathogen identification and monitoring. This integrated solution empowers users to perform advanced molecular testing in the field, generating actionable insights for immediate response and informed decision-making across various sectors.
Target Audience
The primary target audience includes medical professionals, researchers, first responders, and government agencies involved in disease surveillance, biodefense, and environmental monitoring.
Features
- Portable real-time PCR thermocycler for rapid DNA analysis in the field
- Comprehensive suite of assays for detecting infectious diseases, biothreats, and host immune responses
- Mobile app for instrument control, data analysis, and secure result reporting
- Integrated sample preparation system for streamlined workflow
- Cloud-based platform for data management, collaboration, and remote monitoring
- Customizable solutions for diverse applications, including healthcare, biodefense, and environmental monitoring